Conversely, Chen et al. discovered that METTL3 was upregulated in hepatocellular carcinoma patients and was correlated with worse prognosis due to its suppression of cytokine signaling-2 mRNA expression in an m6A-YTHDF2-dependent manner [121]. This evidence concerns the gene METTL3 and hepatocellular carcinoma.